Literature DB >> 9742250

Mechanistic studies on the DNA linking activity of Epstein-Barr nuclear antigen 1.

T M Avolio-Hunter1, L Frappier.   

Abstract

The DNA replication, plasmid segregation and transactivation functions of Epstein-Barr nuclear antigen 1 (EBNA1) require the binding of EBNA1 to specific DNA recognition sites in the two non-contiguous functional elements of the Epstein-Barr virus latent origin of replication, oriP . EBNA1 molecules bound to these elements interact with each other resulting in the formation of looped individual DNA molecules and multiply linked DNA molecules. We have developed a glycerol gradient sedimentation assay suitable for quantitative analysis of the DNA linking activity of EBNA1 and used it to investigate the contribution of EBNA1 residues to the linking interaction and the mechanism of the interaction. Using overlapping internal deletion mutants, we found that two regions of EBNA1 can cause DNA linking, amino acids 40-100 and 327-377, but that the stabilities of the linked complexes formed by the two regions differ dramatically; only complexes formed through the latter region are stable to glycerol gradient sedimentation analysis. Mechanistic studies using EBNA1 in combination with GAL4-EBNA1 fusion proteins showed that linking interactions mediated by residues 327-377 are homotypic. Our results also suggest that only the DNA-bound form of EBNA1 participates in the protein-protein interactions seen in DNA linking.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9742250      PMCID: PMC147874          DOI: 10.1093/nar/26.19.4462

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  13 in total

1.  Functional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus.

Authors:  D F Ceccarelli; L Frappier
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1.

Authors:  Hong Wu; Priya Kapoor; Lori Frappier
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

3.  Role for G-quadruplex RNA binding by Epstein-Barr virus nuclear antigen 1 in DNA replication and metaphase chromosome attachment.

Authors:  Julie Norseen; F Brad Johnson; Paul M Lieberman
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

Review 4.  Hitchhiking of Viral Genomes on Cellular Chromosomes.

Authors:  Tami L Coursey; Alison A McBride
Journal:  Annu Rev Virol       Date:  2019-07-05       Impact factor: 10.431

5.  Regulation of the EBNA1 Epstein-Barr virus protein by serine phosphorylation and arginine methylation.

Authors:  Kathy Shire; Priya Kapoor; Ke Jiang; Margaret Ng Thow Hing; Nirojini Sivachandran; Tin Nguyen; Lori Frappier
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance.

Authors:  K Shire; D F Ceccarelli; T M Avolio-Hunter; L Frappier
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

7.  Epstein-Barr virus (EBV) nuclear antigen 1 colocalizes with cellular replication foci in the absence of EBV plasmids.

Authors:  Sayuri Ito; Kazuo Yanagi
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 8.  Keeping it quiet: chromatin control of gammaherpesvirus latency.

Authors:  Paul M Lieberman
Journal:  Nat Rev Microbiol       Date:  2013-11-06       Impact factor: 60.633

9.  Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1.

Authors:  S C Hung; M S Kang; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

10.  EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication.

Authors:  Feroz Sarkari; Teresa Sanchez-Alcaraz; Shan Wang; Melissa N Holowaty; Yi Sheng; Lori Frappier
Journal:  PLoS Pathog       Date:  2009-10-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.